30-01-2024, 05:49 PM
PUBLISHED MON, JAN 29 20246:54 PM ESTUPDATED MON, JAN 29 202410:15 PM EST
Ashley Capoot
......
The company is developing a brain implant that aims to help patients with severe paralysis control external technologies using only neural signals. Neuralink began recruiting patients for its first in-human clinical trial in the fall after it received approval from the U.S. Food and Drug Administration to conduct the study back in May
......
If the technology functions properly, patients with severe degenerative diseases like ALS could someday use the implant to communicate or access social media by moving cursors and typing with their minds.
https://www.cnbc.com/2024/01/29/elon-mus...-time.html
Ashley Capoot
......
The company is developing a brain implant that aims to help patients with severe paralysis control external technologies using only neural signals. Neuralink began recruiting patients for its first in-human clinical trial in the fall after it received approval from the U.S. Food and Drug Administration to conduct the study back in May
......
If the technology functions properly, patients with severe degenerative diseases like ALS could someday use the implant to communicate or access social media by moving cursors and typing with their minds.
https://www.cnbc.com/2024/01/29/elon-mus...-time.html